Skip to content

PHARMASENSE

Active Risk: not assessed
Private limited companyfounded 201016 yrs activeHeibergstraat(ITE) 17, 2222 Heist-op-den-Berg, BelgiumKBO/BCE: BE 0827.039.024
Summary

PHARMASENSE is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.3m and a net result of €157,945. Equity is growing by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 62% of 8211 sector peers (fiscal year 2025). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
28 d late
2024
26 d late
2023
21 d late
2022
31 d late
2021
39 d early
2020
31 d late
2019
46 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 7 days after the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

PHARMASENSE was incorporated on 25 June 2010.1 Total assets rose from EUR 1.4 million in 2018 to EUR 1.9 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€1.3m▲ 14.4%
2024 · €1.1m
Net result
€157,945▲ 6.0%
2024 · €149,006
Total assets
€1.9m▼ 0.3%
2024 · €1.9m
Solvency
65.1%▲ 8.3pp
2024 · 56.7%
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€188,192▲ 27.4%€220,534▲ 17.2%€237,023▲ 7.5%€234,319▼ 1.1%€240,835▲ 2.8%
Net result€127,058above the sector's middle half▲ 25.6%€156,539above the sector's middle half▲ 23.2%€134,683above the sector's middle half▼ 14.0%€149,006above the sector's middle half▲ 10.6%€157,945above the sector's middle half▲ 6.0%
Equity€954,258above the sector's middle half▲ 15.4%€981,036above the sector's middle half▲ 2.8%€1.1mabove the sector's middle half▲ 13.7%€1.1mabove the sector's middle half▼ 1.6%€1.3mabove the sector's middle half▲ 14.4%
Total assets€1.9mabove the sector's middle half▲ 32.2%€2.0mabove the sector's middle half▲ 1.7%€2.2mabove the sector's middle half▲ 12.5%€1.9mabove the sector's middle half▼ 12.9%€1.9mabove the sector's middle half▼ 0.3%
Debt€987,714▲ 53.9%€993,561▲ 0.6%€1.1m▲ 11.3%€838,030▼ 24.2%€674,451▼ 19.5%
Working capital-€616,184below the sector's middle half▼ 189%-€684,449below the sector's middle half▼ 11.1%-€283,842below the sector's middle half▲ 58.5%-€419,160below the sector's middle half▼ 47.7%-€322,079below the sector's middle half▲ 23.2%
Solvency49.1%within the sector's middle half▼ 7.2pp49.7%within the sector's middle half▲ 0.5pp50.2%within the sector's middle half▲ 0.5pp56.7%within the sector's middle half▲ 6.5pp65.1%within the sector's middle half▲ 8.3pp
Current ratio0.13below the sector's middle half▼ 0.080.16below the sector's middle half▲ 0.020.57below the sector's middle half▲ 0.410.17below the sector's middle half▼ 0.400.17below the sector's middle half=
Return on assets (ROA)6.5%within the sector's middle half▼ 0.3pp7.9%within the sector's middle half▲ 1.4pp6.1%within the sector's middle half▼ 1.9pp7.7%within the sector's middle half▲ 1.6pp8.2%within the sector's middle half▲ 0.5pp
above within below the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2021: €188,192€188,192Net result 2021: €127,058€127,058Operating result 2022: €220,534€220,534Net result 2022: €156,539€156,539Operating result 2023: €237,023€237,023Net result 2023: €134,683€134,683Operating result 2024: €234,319€234,319Net result 2024: €149,006€149,006Operating result 2025: €240,835€240,835Net result 2025: €157,945€157,94520212022202320242025€0€100,000€200,000Operating result 2023: €237,023€237,000Net result 2023: €134,683Operating result 2024: €234,319€234,000Net result 2024: €149,006Operating result 2025: €240,835€241,000Net result 2025: €157,945€158,000202320242025
The operating result recovers in 2025; 2025 is 3% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets €1.9m ▲ 0.9%
Current assets €64,465 ▼ 25.8%
Equity and liabilities €1.9m
Equity €1.3m ▲ 14.4%
Debt €674,451 ▼ 19.5%
Debt's share of the balance-sheet total falls from 43.3% to 34.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
ROE
12.6%▼
2024 · 13.6%
Debt ≤ 1 year
€386,543▼
2024 · €506,002
Debt > 1 year
€284,458▼
2024 · €325,128
Income taxes
€67,999▲
2024 · €65,000
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.9m€1.9m▼
Fixed assets21/28€1.8m€1.9m▲
Tangible fixed assets22/27-€16,744
Other tangible fixed assets26-€16,744
Financial fixed assets28€1.8m€1.8m=
Current assets29/58€86,842€64,465▼
Amounts receivable within one year40/41€18,416€64,459▲
Trade receivables40-€47,459
Other amounts receivable41€18,416€17,000▼
Cash at bank and in hand54/58€68,426€5▼
Equity and liabilities
Total equity and liabilities10/49€1.9m€1.9m▼
Equity10/15€1.1m€1.3m▲
Contributions10/11€18,600€18,600=
Reserves13€1.1m€1.2m▲
Distributable reserves133€1.1m€1.2m▲
Amounts payable17/49€838,030€674,451▼
Amounts payable after more than one year17€325,128€284,458▼
Financial debts170/4€325,128€284,458▼
Amounts payable within one year42/48€506,002€386,543▼
Current portion of amounts payable after more than one year42€124,085€40,670▼
Financial debts43€25,505€25,365▼
Other loans439€25,505€25,365▼
Trade debts44€1,927€3,952▲
Suppliers440/4€1,927€3,952▲
Taxes, remuneration and social security45€16,005€17,080▲
Taxes450/3€16,005€17,080▲
Other amounts payable47/48€338,481€299,476▼
Accrued charges and deferred income492/3€6,900€3,450▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€1,737
Other operating charges640/8€118€1,099▲
Gross operating margin9900€234,437€243,670▲
Operating profit (loss)9901€234,319€240,835▲
Financial charges65/66B€20,312€14,890▼
Recurring financial charges65€20,312€14,890▼
Profit (loss) for the period before taxes9903€214,006€225,944▲
Income taxes67/77€65,000€67,999▲
Profit (loss) for the period9904€149,006€157,945▲
Profit (loss) for the period to be appropriated9905€149,006€157,945▲
Appropriation of the result
Profit (loss) to be appropriated9906€149,006€157,945▲
Transfer from equity791/2€167,139-
Transfer to equity691/2€149,006€157,945▲
To other reserves6921€149,006€157,945▲
Profit to be distributed694/7€167,139-
Return on contributions (dividend)694€167,139-

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630----€1,737-
Other operating charges640/8€969€970€1,069€118€1,099▲ 832%
Gross operating margin9900€189,161€221,504€238,092€234,437€243,670▲ 3.9%
Operating profit (loss)9901€188,192€220,534€237,023€234,319€240,835▲ 2.8%
Financial income75/76B--€414---
Recurring financial income75--€414---
Financial charges65/66B€15,556€12,387€22,280€20,312€14,890▼ 26.7%
Recurring financial charges65€15,556€12,387€22,280€20,312€14,890▼ 26.7%
Profit (loss) for the period before taxes9903€172,635€208,147€215,157€214,006€225,944▲ 5.6%
Income taxes67/77€45,577€51,609€80,474€65,000€67,999▲ 4.6%
Profit (loss) for the period9904€127,058€156,539€134,683€149,006€157,945▲ 6.0%
Profit (loss) for the period to be appropriated9905€127,058€156,539€134,683€149,006€157,945▲ 6.0%
Line20212022202320242025Change
Assets
Total assets20/58€1.9m€2.0m€2.2m€1.9m€1.9m▼ 0.3%
Fixed assets21/28€1.8m€1.8m€1.8m€1.8m€1.9m▲ 0.9%
Tangible fixed assets22/27----€16,744-
Other tangible fixed assets26----€16,744-
Financial fixed assets28€1.8m€1.8m€1.8m€1.8m€1.8m=
Current assets29/58€93,198€125,822€372,485€86,842€64,465▼ 25.8%
Amounts receivable within one year40/41€2,319€38,576€119,410€18,416€64,459▲ 250%
Trade receivables40-€32,452€26,644-€47,459-
Other amounts receivable41€2,319€6,124€92,765€18,416€17,000▼ 7.7%
Cash at bank and in hand54/58€38,784€87,246€253,004€68,426€5▼ 100.0%
Deferred charges and accrued income490/1€52,095-€71---
Equity and liabilities
Total equity and liabilities10/49€1.9m€2.0m€2.2m€1.9m€1.9m▼ 0.3%
Equity10/15€954,258€981,036€1.1m€1.1m€1.3m▲ 14.4%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€935,658€962,436€1.1m€1.1m€1.2m▲ 14.6%
Non-distributable reserves130/1€1,860€1,860----
Reserves not available under the articles1311€1,860€1,860----
Distributable reserves133€933,798€960,576€1.1m€1.1m€1.2m▲ 14.6%
Amounts payable17/49€987,714€993,561€1.1m€838,030€674,451▼ 19.5%
Amounts payable after more than one year17€278,331€183,289€449,213€325,128€284,458▼ 12.5%
Financial debts170/4€278,331€183,289€449,213€325,128€284,458▼ 12.5%
Amounts payable within one year42/48€709,383€810,272€656,327€506,002€386,543▼ 23.6%
Current portion of amounts payable after more than one year42€91,715€95,042€136,440€124,085€40,670▼ 67.2%
Financial debts43€15,463€15,484€17,027€25,505€25,365▼ 0.5%
Other loans439€15,463€15,484€17,027€25,505€25,365▼ 0.5%
Trade debts44€589€627€843€1,927€3,952▲ 105%
Suppliers440/4€589€627€843€1,927€3,952▲ 105%
Taxes, remuneration and social security45€1,050€7,538€21,011€16,005€17,080▲ 6.7%
Taxes450/3€1,050€7,538€21,011€16,005€17,080▲ 6.7%
Other amounts payable47/48€600,566€691,579€481,006€338,481€299,476▼ 11.5%
Accrued charges and deferred income492/3---€6,900€3,450▼ 50.0%
Line20212022202320242025Change
Profit (loss) for the period9904€127,058€156,539€134,683€149,006€157,945▲ 6.0%
+ Depreciation and write-downs630----€1,737-
Operating cash flow (approximation)€127,058€156,539€134,683€149,006€159,682▲ 7.2%
Investment in fixed assets (approximation)-€0€0€0-€18,480-
Change in cash-€48,462€165,758-€184,578-€68,421▲ 62.9%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
28-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-12
Financial Highest result since 2018net €157,945 ▲6%
Operating result €240,835, net result €157,945, both a record.
26-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
21-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 21 days late
2023
31-12
Financial Equity above €1mEq €1.1m ▲13.7%
6 profitable years in a row build equity to €1.1m.
31-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
22-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
15-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
16-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
19-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Heist-op-den-Berg · 1 establishment unit since 2010
seat establishment The establishment unit on the map
Ground area
1,165 m²
Building footprint
262 m²
Volume, LiDAR
1,504 m³
Parcel 12017C0153/00D002, Flanders · tallest building 10.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PHARMASENSE
Heibergstraat(ITE) 17, 2222 Heist-op-den-BergHoldings
since 20102.189.512.803
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12017C0153/00D002 Flanders 1,165 m² 1 · 262 m² 10.8 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 1

According to the 2025 annual accounts of PHARMASENSE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 24,721 companies in this sector we hold annual accounts for 19,804. 12,179 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPrivate limited company
Founded25-06-2010
Fiscal year end31-12
Activities, NACEBEL 2025
64210Activities of holding companies
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0827039024
Also 9925:BE0827039024
Registered 29-04-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.